Sernova (SVA) Competitors C$0.20 0.00 (0.00%) As of 02/21/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades SVA vs. ABCN, EMC, FRX, BCT, IPA, SCYB, COM, MDNA, NVH, and IGXShould you be buying Sernova stock or one of its competitors? The main competitors of Sernova include VIVO Cannabis (ABCN), Emblem (EMC), Fennec Pharmaceuticals (FRX), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Medicenna Therapeutics (MDNA), Novoheart (NVH), and IntelGenx Technologies (IGX). These companies are all part of the "biotechnology" industry. Sernova vs. VIVO Cannabis Emblem Fennec Pharmaceuticals BriaCell Therapeutics ImmunoPrecise Antibodies Scythian Biosciences 138267 (COM.TO) Medicenna Therapeutics Novoheart IntelGenx Technologies VIVO Cannabis (CVE:ABCN) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership. Do institutionals & insiders have more ownership in ABCN or SVA? 0.1% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor ABCN or SVA? VIVO Cannabis received 117 more outperform votes than Sernova when rated by MarketBeat users. However, 91.67% of users gave Sernova an outperform vote while only 71.91% of users gave VIVO Cannabis an outperform vote. CompanyUnderperformOutperformVIVO CannabisOutperform Votes12871.91% Underperform Votes5028.09% SernovaOutperform Votes1191.67% Underperform Votes18.33% Does the media refer more to ABCN or SVA? In the previous week, Sernova had 1 more articles in the media than VIVO Cannabis. MarketBeat recorded 1 mentions for Sernova and 0 mentions for VIVO Cannabis. Sernova's average media sentiment score of 0.67 beat VIVO Cannabis' score of 0.00 indicating that Sernova is being referred to more favorably in the news media. Company Overall Sentiment VIVO Cannabis Neutral Sernova Positive Is ABCN or SVA more profitable? Sernova's return on equity of 473.85% beat VIVO Cannabis' return on equity.Company Net Margins Return on Equity Return on Assets VIVO CannabisN/A N/A N/A Sernova N/A 473.85%-119.26% Which has preferable earnings and valuation, ABCN or SVA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVIVO CannabisN/AN/AN/AN/AN/ASernovaN/AN/A-C$35.70M-C$0.10-1.93 Do analysts recommend ABCN or SVA? Sernova has a consensus price target of C$1.83, suggesting a potential upside of 816.67%. Given Sernova's stronger consensus rating and higher possible upside, analysts clearly believe Sernova is more favorable than VIVO Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VIVO Cannabis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sernova 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummarySernova beats VIVO Cannabis on 10 of the 12 factors compared between the two stocks. Get Sernova News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SVA vs. The Competition Export to ExcelMetricSernovaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$67.30MC$118.00MC$5.84BC$5.70BDividend Yield7.86%3.69%4.75%6.47%P/E Ratio-1.933.2026.1530.24Price / SalesN/A4,826.69435.33480.11Price / Cash6.1513.0138.0182.82Price / Book-4.6847.077.643.84Net Income-C$35.70M-C$87.82MC$3.19BC$298.40M7 Day PerformanceN/A0.38%-2.11%-1.07%1 Month Performance-2.44%3.67%-0.49%1.42%1 Year Performance-69.23%99.17%16.44%38.10% Sernova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SVASernova2.0691 of 5 starsC$0.20flatC$1.83+816.7%-70.6%C$67.30MN/A-1.931,959ABCNVIVO CannabisN/AC$1.32+5.6%N/A+0.0%C$256.62MN/A0.00N/AGap UpEMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AFRXFennec PharmaceuticalsN/AC$9.80+3.3%N/A-21.0%C$188.99MC$34.86M-166.0110Gap UpBCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownSCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/AMDNAMedicenna TherapeuticsN/AC$1.34+1.5%N/A+6.5%C$100.25MC$4,868.39-3.6920NVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap Up Related Companies and Tools Related Companies VIVO Cannabis Alternatives Emblem Alternatives Fennec Pharmaceuticals Alternatives BriaCell Therapeutics Alternatives ImmunoPrecise Antibodies Alternatives Scythian Biosciences Alternatives 138267 (COM.TO) Alternatives Medicenna Therapeutics Alternatives Novoheart Alternatives IntelGenx Technologies Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:SVA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sernova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SVA Stock Alerts